Earnings summaries and quarterly performance for Global Medical REIT.
Executive leadership at Global Medical REIT.
Board of directors at Global Medical REIT.
Research analysts who have asked questions during Global Medical REIT earnings calls.
AW
Austin Wurschmidt
KeyBanc Capital Markets Inc.
4 questions for GMRE
Also covers: AHR, AIV, AMH +20 more
Gaurav Mehta
Alliance Global Partners
4 questions for GMRE
Also covers: ALEX, BRSP, CLDT +12 more
Juan Sanabria
BMO Capital Markets
3 questions for GMRE
Also covers: AMH, BRX, CTRE +20 more
WG
Wesley Golladay
Robert W. Baird & Co.
3 questions for GMRE
Also covers: ADC, AHR, ARE +23 more
John Massocca
B. Riley Financial
2 questions for GMRE
Also covers: BEEP, CMCT, CTO +13 more
Robert Stevenson
Janney Montgomery Scott LLC
2 questions for GMRE
Also covers: ADC, AHH, AIV +17 more
Alec Feygin
Robert W. Baird & Co. Incorporated
1 question for GMRE
Also covers: CTRE, FCPT, KIM +6 more
BM
Bryan Maher
B. Riley Securities
1 question for GMRE
Also covers: BEEP, DHC, GNL +8 more
Robin Haneland
BMO Capital Markets
1 question for GMRE
Also covers: NHI, NSA
Recent press releases and 8-K filings for GMRE.
Global Medical REIT Inc. Announces Issuance of 8.00% Series B Cumulative Redeemable Preferred Stock
GMRE
Dividends
Convertible Preferred Issuance
- Global Medical REIT Inc. (GMRE) announced the issuance and sale of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock at a public offering price of $25.00 per share, totaling $50,000,000.
- The Series B Preferred Stock will pay cumulative cash dividends at an annual rate of 8.00% (equivalent to $2.00 per annum per share), accruing from November 20, 2025.
- Dividends will be paid quarterly in arrears on January 31, April 30, July 31, and October 31 of each year, commencing January 31, 2026.
- The stock is perpetual but redeemable by GMRE on or after November 20, 2030, at $25.00 per share plus accrued and unpaid dividends, and includes a conversion right for holders upon a change of control.
- GMRE intends to file an application to list the Series B Preferred Stock on the NYSE under the symbol "GMRE-PrB".
Nov 18, 2025, 9:15 PM
Global Medical REIT Inc. Reports Q3 2025 Results
GMRE
Earnings
Debt Issuance
- Global Medical REIT Inc. reported a net loss attributable to common stockholders of approximately $6.0 million, or $0.45 per diluted share, for the third quarter ended September 30, 2025.
- For the third quarter of 2025, the company achieved 2.7% year-over-year same-store cash net operating income growth.
- As of September 30, 2025, the company's portfolio was 95.2% occupied, comprising approximately 5.2 million leasable square feet with an annualized base rent of approximately $118.4 million.
- The Net Debt / Annualized Adjusted EBITDA_re_ ratio for the quarter ended September 30, 2025, was 6.9x.
Nov 13, 2025, 1:45 PM
GLOBAL MEDICAL REIT Reports Q3 2025 Results
GMRE
Earnings
Share Buyback
Debt Issuance
- GLOBAL MEDICAL REIT reported a net loss attributable to common stockholders of $6.0 million, or $0.45 per diluted share, for Q3 2025, primarily due to a $6.3 million impairment charge related to a facility in Aurora, IL.
- Funds from operations (FFO) increased to $14.5 million, or $1.00 per share and unit, and Adjusted funds from operations (AFFO) increased to $16.2 million, or $1.12 per share and unit, both representing a 4% year-over-year increase on a per share and unit basis.
- As of September 30, 2025, the company maintained a portfolio leased occupancy of 95.2% and achieved Same-Store Cash Net Operating Income (NOI) growth of 2.7% on a year-over-year basis.
- In September 2025, GLOBAL MEDICAL REIT completed a one-for-five reverse stock split, and in August 2025, established a $50 million common stock repurchase program, though no shares had been repurchased as of November 3, 2025.
- Consolidated debt outstanding was $713 million as of September 30, 2025, with a leverage ratio of 47.3% and Net Debt / Annualized Adjusted EBITDAre of 6.9x. The credit facility was amended in October 2025 to extend maturities.
Nov 5, 2025, 2:00 PM
GMRE Reports Q3 2025 Financial Results and Strategic Updates
GMRE
Earnings
Debt Issuance
Share Buyback
- Global Medical REIT (GMRE) reported Q3 2025 Funds From Operations (FFO) of $1.00 per share and Adjusted Funds From Operations (AFFO) of $1.12 per share, with both metrics growing 4% on a per-share basis relative to the prior year.
- The company's portfolio achieved 2.7% same-store Net Operating Income (NOI) growth and was 95.2% leased with a 5.3-year weighted average lease term (WALT) as of quarter-end, with expectations for occupancy to trend towards 96% by year-end.
- GMRE proactively managed its balance sheet by extending its revolver to 2029 and its $350 million term loan A into three tranches maturing between October 2029 and April 2031, while also removing a 10 basis point SOFR credit spread from its credit facility borrowings.
- The company is evaluating a $500 million acquisition pipeline with 7.5%-8% first-year cash returns and plans to fund transactions through asset recycling, with a near-term disposition pipeline of $50-$100 million, and is also considering share buybacks and preferred stock as capital options.
Nov 5, 2025, 2:00 PM
Global Medical REIT Announces Third Quarter 2025 Financial Results
GMRE
Earnings
Share Buyback
Debt Issuance
- Global Medical REIT Inc. reported a net loss attributable to common stockholders of $6.0 million, or $0.45 per diluted share, for the third quarter of 2025, primarily due to a $6.3 million impairment charge. Despite this, Funds From Operations (FFO) increased 4% year-over-year to $1.00 per share and unit, and Adjusted Funds From Operations (AFFO) increased 4% year-over-year to $1.12 per share and unit.
- Rental revenue grew 8.4% year-over-year to $37.0 million for Q3 2025, with Same-Store Cash Net Operating Income (NOI) growth of 2.7%. Portfolio leased occupancy stood at 95.2% as of September 30, 2025.
- The company completed a one-for-five reverse stock split in September 2025 and established a $50 million common stock repurchase program in August 2025. Additionally, in October 2025, the credit facility was amended to extend maturities, increasing the weighted average maturity from 1.3 years to 4.4 years.
Nov 4, 2025, 10:04 PM
Global Medical REIT Announces Third Quarter 2025 Financial Results and Strategic Actions
GMRE
Earnings
Share Buyback
Guidance Update
- Global Medical REIT reported a net loss of $6.0 million, or $0.45 per diluted share, for the third quarter of 2025, primarily due to a $6.3 million impairment charge. However, Funds from Operations (FFO) increased 4% year-over-year to $1.00 per share and unit, and Adjusted Funds from Operations (AFFO) increased 4% to $1.12 per share and unit for the same period.
- The company completed a one-for-five reverse stock split in September 2025 and established a $50 million common stock repurchase program in August 2025.
- In October 2025, Global Medical REIT amended and restated its credit facility to extend the maturities of its revolver and Term Loan A components, with the revolver now maturing in October 2029 (with extension options to October 2030) and Term Loan A components maturing between October 2029 and April 2031.
- The company narrowed its full year 2025 AFFO per share and unit guidance range to $4.50 to $4.60.
Nov 4, 2025, 9:05 PM
Global Medical REIT Inc. Amends and Restates Credit Facility
GMRE
Debt Issuance
- Global Medical REIT Inc. (GMRE) entered into an amended and restated credit facility on October 8, 2025, which extends the maturities of its borrowings.
- The $400 million revolver component now has an initial maturity date of October 2029, with two six-month extension options available to extend it to October 2030.
- The existing $350 million Term Loan A was restructured into three term loans: $100 million maturing in October 2029, $100 million maturing in October 2030, and $150 million maturing in April 2031.
- The amendment removed the previous 0.10% (10 basis point) SOFR credit spread adjustment on all credit facility borrowings.
- This change increased the weighted average term of the Company's debt from 1.3 years to 4.4 years at the closing of the Amended and Restated Credit Facility.
Oct 8, 2025, 8:25 PM
GMRE Amends and Restates Credit Facility
GMRE
Debt Issuance
- Global Medical REIT Inc. (GMRE) amended and restated its credit facility, extending the initial maturity date of its $400 million revolver component to October 2029 (with options to extend to October 2030) and restructuring the $350 million Term Loan A into three tranches maturing between October 2029 and April 2031.
- In connection with the amendment, GMRE entered into $350 million of forward starting interest rate swaps to fully hedge the SOFR component of the new Term Loan A tranches through their respective maturities, resulting in effective interest rates between 4.75% and 4.84%.
- The company also removed the previous 0.10% secured overnight financing rate (SOFR) credit spread adjustment on all credit facility borrowings.
- At the closing of the Amended and Restated Credit Facility, the weighted average term of GMRE's debt increased to 4.4 years.
Oct 8, 2025, 8:05 PM
Global Medical REIT Declares 2025 Third Quarter Dividends
GMRE
Dividends
- Global Medical REIT Inc. (GMRE) Board has declared a 2025 third quarter cash dividend of $0.75 per share of common stock and unit.
- This common dividend is payable on October 15, 2025, to common stockholders of record as of September 29, 2025, and reflects a one-for-five reverse stock split, equating to $0.15 per share on a pre-split basis.
- The Board also declared a quarterly cash dividend of $0.46875 per share on its Series A Cumulative Redeemable Preferred Stock, payable on October 31, 2025, to stockholders of record as of October 15, 2025.
Sep 3, 2025, 8:05 PM
Quarterly earnings call transcripts for Global Medical REIT.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more